Cerevel Therapeutics Announces Positive Topline Results for Dari
CERE: Cerevel Therapeutics Holdings, Inc.
2022-02-15 06:30:00
Cerevel Therapeutics Announces Positive Topline Results for Darigabat in Phase 1 Clinical Trial in Acute Anxiety
2022-02-15 06:30:00
Cerevel Therapeutics Announces Positive Topline Results for Darigabat in Phase 1 Clinical Trial in Acute Anxiety
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.